A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Center for International Blood and Marrow Transplant Research
Takeda
Thomas Jefferson University
Cogent Biosciences, Inc.
Ossium Health, Inc.
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
Washington University School of Medicine
University of Michigan Rogel Cancer Center
Novartis
Constellation Pharmaceuticals
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Cogent Biosciences, Inc.
Novartis
Masonic Cancer Center, University of Minnesota
Baptist Health South Florida
Takeda
Baylor College of Medicine
Hoffmann-La Roche
Takeda
University of Rochester
Novartis
University of Illinois at Chicago
Pfizer
Novartis
Phoenix Children's Hospital
Bellicum Pharmaceuticals
CTI BioPharma
Gilead Sciences
Sierra Oncology LLC - a GSK company
Novartis
M.D. Anderson Cancer Center
Celgene
Fred Hutchinson Cancer Center
Novartis
Celgene
Sunesis Pharmaceuticals
M.D. Anderson Cancer Center
Beth Israel Deaconess Medical Center
Baylor College of Medicine
Seagen Inc.
Il-Yang Pharm. Co., Ltd.
National Heart, Lung, and Blood Institute (NHLBI)
AOP Orphan Pharmaceuticals AG
M.D. Anderson Cancer Center
Seagen Inc.
Ariad Pharmaceuticals
Scios, Inc.